Literature DB >> 416942

[Qualitative and quantitative EEG-findings in schizophrenia (author's transl)].

T M Itil.   

Abstract

The results of the qualitative but particularly the quantitative EEG-studies indicate that 1. The EEG of adult schizophrenics is characterized by an appearance of excessive fast activity along with some slow waves and the lack of alpha-activity. 2. Excessive fast activity and lack of alpha-waves have also been found in the EEGs of psychotic children and most interestingly in children whose parents (particularly the mother) are schizophrenic (high risk children). 3. Based on the studies during sleep and investigations with neuroleptics, it was established that the origin of the excess fast activity in schizophrenia cannot be the muscle potential. Particularly the excess fast activity in high risk children for schizophrenia goes against the muscle potential hypothesis. 4. The quantitative EEG changes seen in schizophrenia show similarity to those seen after hallucinogenic compounds particularly after anticholinergic hallucinogenics. 5. All neuroleptics (major tranquilizers) produce quantitative EEG alterations which are almost diametrically opposite to those seen in schizoprenia.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 416942

Source DB:  PubMed          Journal:  EEG EMG Z Elektroenzephalogr Elektromyogr Verwandte Geb        ISSN: 0012-7590


  3 in total

1.  The electroencephalogram (EEG) as a research tool in human behavior genetics: psychological examinations in healthy males with various inherited EEG variants. III. Interpretation of the results.

Authors:  F Vogel; E Schalt
Journal:  Hum Genet       Date:  1979-02-28       Impact factor: 4.132

2.  Neurobiological approaches in human behavior genetics.

Authors:  F Vogel
Journal:  Behav Genet       Date:  1981-03       Impact factor: 2.805

3.  Inefficient Preparatory fMRI-BOLD Network Activations Predict Working Memory Dysfunctions in Patients with Schizophrenia.

Authors:  Anja Baenninger; Laura Diaz Hernandez; Kathryn Rieger; Judith M Ford; Mara Kottlow; Thomas Koenig
Journal:  Front Psychiatry       Date:  2016-03-18       Impact factor: 4.157

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.